Brief description
Scabies infestation status of human participants from a remote Aboriginal community in Northern Australia.
Full description
Scabies is endemic in many Australian Aboriginal and Torres Strait Islander communities, with 69% of infants infected in the first year of life. Previous mass drug administration (MDA) programs using topical acaricides to decrease scabies prevalence have had varying degrees of success in Australia. We were invited by one community in eastern Arnhem Land to develop and deliver an oral-ivermectin MDA. Utilizing a before and after study design, we measured scabies prevalence through population census with sequential MDAs at baseline and month 12. Scabies prevalence fell from 4% at baseline to 1% at month 6, rising to 9% at month 12 in association with an identified exposure to a presumptive crusted scabies case. For new entries to the cohort at month 12 scabies prevalence was higher at 14%. We were able to demonstrate a reduction in scabies prevalence in the six months after each MDA with a low risk of acquisition (1–2%); however, a sustained reduction was not achieved.
Funding Scheme
NHMRC Grant ID: 605804
Impact of an ivermectin mass drug administration program against endemic scabies and strongyloidiasis
https://www.nhmrc.gov.au/national_register_public_health_research/49352
Funding Amount
Funding amount/budget: $1,289,786
Available: 30 10 2015 to 02 11 2015
Data time period: 01 03 2010 to 31 10 2012
User Contributed Tags
Login to tag this record with meaningful keywords to make it easier to discover
